Wall Street learned on Tuesday that multinational pharmaceutical giant AstraZeneca has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after a suspected serious adverse reaction in a study participant. According to health news website, which quoted an AstraZeneca spokesperson, the “standard review process triggered a pause to vaccination to allow review … Continue reading “AstraZeneca Pauses Late Stage COVID-19 Vaccine Trial”
